Efficacy of dose-dense chemotherapy as first-line treatment of advanced ovarian cancer patients after non-optimal debulking.

被引：0
|
作者：
Rumyantsev, Alexey
Tyulyandina, Alexandra
Pokataev, Ilya
Morkhov, Konstantin
Nechuskina, Valentina Mikhailovna
Tjulandin, Sergei
机构：
[1] Minist Hlth Russian Federat NN Blokhin NMRCO, Fed State Budgetary Inst, NN Blokhin Natl Med Res Ctr Oncol, Moscow, Russia
[2] Russian Canc Res Ctr, Moscow, Russia
[3] NN Blokhin Russian Canc Res Ctr, Moscow, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18066
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Bevacizumab with Chemotherapy as a First-Line Treatment for Advanced Ovarian Cancer in a Serbian Cohort
    Conic, Irena
    Nedovic, Bojan
    Stojnev, Slavica
    Todorovska, Ilinka
    Dimitrijevic, Aleksandra
    Krstic, Miljan
    Djordjevic, Ivana
    Djordjevic, Biljana
    MEDICINA-LITHUANIA, 2022, 58 (05):
  • [22] Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first line chemotherapy, in advanced breast cancer.
    Fountzilas, G
    Papadimitriou, C
    Bafaloukos, D
    Skarlos, D
    Kalofonos, HP
    Aravantinos, G
    Papakostas, P
    Kosmidis, P
    Pavlidis, N
    Dimopoulos, MA
    ANNALS OF ONCOLOGY, 2000, 11 : 26 - 26
  • [23] Dose-dense carboplatin and paclitaxel versus three weekly regimen in the first-line treatment of ovarian carcinoma.
    Pirolli, Rafaela
    Estati, Felipe Leonardo
    Alencar, Viviane
    de Oliveira, Mariana Romero
    Goncalves Ribeiro, Adriana Regina
    Baiocchi, Glauco
    Guimaraes, Andrea Paiva
    Da Costa, Alexandre Andre B. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [24] Long-term survival after dose-dense high-dose chemotherapy with progenitor cell support as primary treatment for patients with advanced ovarian cancer
    Eisenhauer, E. L.
    Tew, W. P.
    Sabbatini, P. J.
    Spriggs, D. R.
    Chi, D. S.
    Barakat, R. R.
    Aghajanian, C.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S41 - S42
  • [25] Efficacy of Ipilimumab in Combination with Chemotherapy for First-Line Treatment of Advanced Lung Cancer
    Htut, T.
    Tun, A.
    Swarup, S.
    Sultan, A.
    Mogollon-Duffo, F.
    Jahan, N.
    Adhikari, N.
    Oo, Y.
    Thida, A.
    Aung, H.
    Thi, W.
    Panigrahi, K.
    Tijani, L.
    Thein, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S743 - S743
  • [26] Dose-Dense Paclitaxel With Carboplatin for Advanced Ovarian Cancer: A Feasible Treatment Alternative
    Glaze, Sarah
    Teitelbaum, Lisa
    Chu, Pamela
    Ghatage, Prafull
    Nation, Jill
    Nelson, Gregg
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2013, 35 (01) : 61 - 67
  • [27] Chemotherapy efficacy after first-line immunotherapy in 18 advanced melanoma patients
    Saint-Jean, Melanie
    Fronteau, Clementine
    Peuvrel, Lucie
    Khammari, Amir
    Varey, Emilie
    Quereux, Gaelle
    Dreno, Brigitte
    MEDICINE, 2020, 99 (29) : E21329
  • [28] Bevacizumab in the First-line Treatment of advanced Ovarian Cancer
    Mallmann, Michael R.
    Alakus, Hakan
    Mallmann, Peter
    Bruns, Christiane
    ONKOLOGE, 2019, 25 (11): : 1020 - 1021
  • [29] Neoadjuvant chemotherapy as first-line treatment of Danish patients with advanced ovarian cancer: Major regional differences
    Fago-Olsen, Carsten
    Ottesen, Bent
    Markauskas, Algirdas
    Mosgaard, Berit
    Ottosen, Christian
    Sogaard, Charlotte
    Sogaard-Andersen, Erik
    Hogdall, Claus
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2012, 91 : 17 - 18
  • [30] Dose-dense biweekly docetaxel combined with 5-fluorouracil as first-line treatment in advanced gastric cancer: a phase II trial
    Xiao, Jian
    Chen, Yonghe
    Li, Wenyun
    Gong, Jiaying
    Zhou, Zhiyang
    Deng, Yanhong
    Wang, Lei
    Ren, Donglin
    Wang, Jianping
    Peng, Junsheng
    Lan, Ping
    MEDICAL ONCOLOGY, 2015, 32 (02)
12345